Worldwide Clinical Trials Launches Large Molecule Services

Worldwide Clinical Trials, Inc. has announced the extension of its service offerings to include large molecule capabilities, now integrated into its preexisting clinical pharmacology and pharmacokinetics business unit. Capabilities include pharmacodynamic studies, pharmacokinetics, biomarker assays, and immunogenicity testing.

Read more about the new service offerings here.